Govt passes National Institute of Pharmaceutical Education and Research (Amendment) Bill, 2021

New Delhi, Dec 6: The Centre passed the National Institute of Pharmaceutical Education and Research (Amendment) Bill, 2021 on Monday.

The Bill, which was introduced by Union Health Minister Mansukh Mandaviya, accords special status to six more institutes of pharmaceutical education and research as well as set up a council for these institutes.

The Bill was introduced in Lok Sabha in March this year and referred thereafter to the Standing Committee on Chemicals and Fertilisers. It seeks to amend the National Institute of Pharmaceutical Education and Research Act, 1998, which established the National Institute of Pharmaceutical Education and Research (NIPER), at Mohali in Punjab and declared it as an Institution of National Importance.

With the amendment, six more institutes of pharmaceutical education and research has been be declared as Institutions of National Importance. These institutes are at Ahmedabad, Guwahati, Hajipur, Hyderabad, Kolkata and Raebareli. It also proposes to bring down the membership of the board of governors - mandated to manage the institute's affairs - of each NIPER from the current 23 to 12 members.

Reacting to the removal of three MPs from the governing council, Abdul Khalek from the Congress said that MPs are representative of people and can provide better insight to any institutions as they are connected to public. The bill brings down the number of members from 23 to 12.

Saugata Roy (TMC) demanded that the government provide permanent campus to these institutes. Stressing that there is urgent need to focus on capacity building, BJP's Rajdeep Roy said it will help train manpower required by industry.

Participating in the discussion, Sanjeev Kumar Singari (YSRCP) said industrialists should be incentivised for every research undertaken. He also said the country's youth are quite talented and there is a need to train them in the pharma sector. Alok Kumar Suman of JD(U) said with this Bill, research in the pharmaceutical sector will be strengthened. Kunwar Danish Ali (BSP) termed the bill "very important" and stressed that there is a need for strict accountability while carrying out the trial for any medicine.

He was also of the view that the government should allocate more money for research in the pharma sector. Supriye Sule of the NCP was of the view that there should be serious investment in the laboratories. PTI